Prognostic significance of TP53 alterations in breast carcinoma
1993 · British Journal of Cancer · 167 citations
https://doi.org/10.1038/bjc.1993.383
K
Ketil Heimdal
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
7.5K
Citations
41
h-index
93
i10-index
Ketil Heimdal is an academic researcher from Oslo University Hospital. The author has contributed to research in topics: BRCA gene mutations in cancer & Testicular diseases and treatments & Genetic factors in colorectal cancer. The author has an h-index of 41, co-authored 134 publications.
ORCID: 0000-0002-8911-3508Papers by this author
worksCiliopathy patient variants reveal organelle-specific functions for TUBB4B in axonemal microtubules
2024 · Science · 41 citations
https://doi.org/10.1126/science.adf5489
Renal Amyloidosis Associated With 5 Novel Variants in the Fibrinogen A Alpha Chain Protein
2016 · Kidney International Reports · 36 citations
https://doi.org/10.1016/j.ekir.2016.11.005
Effectiveness and safety of everolimus treatment in patients with tuberous sclerosis complex in real-world clinical practice
2023 · Orphanet Journal of Rare Diseases · 23 citations
https://doi.org/10.1186/s13023-023-02982-1
Germline PTEN mutations are rare and highly penetrant
2006 · Hereditary Cancer in Clinical Practice · 18 citations
https://doi.org/10.1186/1897-4287-4-4-177
[European guidelines for health care in hereditary breast cancer].
2000 · PubMed · 2 citations
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat